Ken Griffin Atai Life Sciences N.V. Transaction History
Citadel Advisors LLC
- $509 Billion
- Q1 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Atai Life Sciences N.V. stock. As of the latest transaction made, Citadel Advisors LLC holds 77,400 shares of ATAI stock, worth $102,942. This represents 0.0% of its overall portfolio holdings.
Number of Shares
77,400
Previous 28,700
169.69%
Holding current value
$102,942
Previous $40,000
280.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding ATAI
# of Institutions
96Shares Held
13.1MCall Options Held
229KPut Options Held
114K-
Morgan Stanley New York, NY2.67MShares$3.55 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.22MShares$2.95 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.4MShares$1.86 Million0.0% of portfolio
-
Marshall Wace, LLP London, X0794KShares$1.06 Million0.0% of portfolio
-
Brown University719KShares$955,6050.61% of portfolio
About ATAI Life Sciences N.V.
- Ticker ATAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 165,875,008
- Market Cap $221M
- Description
- Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...